[The application value of BI-RADS lexicon and high-frequency CDFI scoring in differentiation of benign from malignant lesions of the breast].

OBJECTIVE: To explore the diagnostic value with BI-RADS lexicon and high-frequency color doppler ultrasonic scoring for breast diseases. METHODS: A total of 108 breast lesions were studied with BI-RADS lexicon and high-frequency color doppler ultrasonic scoring, and compared with pathologic results. Calculated the sensitivity, specificity, accuracy, positive predictive value, and negative predictive value. RESULTS: Of these 108 lesions, 65(60.19%) were pathologically confirmed to be benign and 43(39.82%) to be malignant. There were no statistically significant differences between BI-RADS lexicon and high-frequency color doppler ultrasonic scoring in the diagnosis of breast lesions (P > 0.05). CONCLUSION: Both of BI- RADS lexicon and high-frequency color doppler ultrasonic scoring have a higher value for diagnosing breast disease in clinical application, and BI-RADS lexicon provides the normalized and standardized reporting data for clinical doctor in diagnosing breast disease, It is more conducive to guide clinicians with correct judgment and active treatment for breast disease.

[Diagnostic values of breast imaging and reporting data system and ultrasonic elastography for benign and malignant breast lesions].

OBJECTIVE: To explore the diagnostic values of breast imaging and reporting data system (BI-RADS) and ultrasonic elastography (UE) for benign and malignant breast lesions. METHODS: A total of 122 breast lesions were studied with BI-RADS and UE scoring to compare the sensitivity and specificity according to the pathologic results. Receiver operating characteristic (ROC) curves were used to assess the diagnostic value of BI-RADS, UE and combination. RESULTS: Among them, pathological examinations showed that there were 72 benign and 50 malignant cases. Statistically significant differences in specificity existed between BI-RADS lexicon (as ≥ 4) and UE or combination (P < 0.05) while sensitivity showed no difference (P > 0.05); Statistically significant differences in sensitivity existed between BI-RADS (as ≥ 4B) and UE or combination (P < 0.05) while there was no difference in specificity (P > 0.05); No statistically significant differences existed between UE or combination. The area under the ROC curve was above 0.7. CONCLUSION: Both BI-RADS and UE have a great diagnostic value for breast disease. UE is somewhat superior to BI-RADS. However, the value of combination may be more significant.